{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:13:51Z","timestamp":1773738831288,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2146,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.virol.2007.04.010","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T13:32:02Z","timestamp":1179408722000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge"],"prefix":"10.1016","volume":"366","author":[{"given":"Pragati","family":"Nigam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia L.","family":"Earl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Americo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Edghill-Spano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi S.","family":"Chennareddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Silvera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama Rao","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2007.04.010_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.292.5514.69","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.virol.2007.04.010_bib2","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/JVI.76.12.6138-6146.2002","article-title":"Critical role for Env as well as Gag-Pol for the control of a pathogenic SHIV challenge by a DNA\/rMVA Vaccine","volume":"76","author":"Amara","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.04.010_bib3","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1128\/JVI.76.15.7625-7631.2002","article-title":"Different patterns of immune responses but similar control of a mucosal immunodeficiency virus challenge by MVA and DNA\/MVA vaccines","volume":"76","author":"Amara","year":"2002","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2007.04.010_bib4","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of cD4 than CD8 T cells","volume":"78","author":"Amara","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2007.04.010_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2005.01.026","article-title":"Studies on the cross-clade and cross-species conservation of HIV-1 Gag-Specific CD8 and CD4 T cell responses elicited by a clade B DNA\/MVA vaccine in macaques","volume":"334","author":"Amara","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2007.04.010_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2007.04.010_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J. Gen. Virol."},{"issue":"11","key":"10.1016\/j.virol.2007.04.010_bib8","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.75.11.5151-5158.2001","article-title":"Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination","volume":"75","author":"Barouch","year":"2001","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virol.2007.04.010_bib9","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt. 5","key":"10.1016\/j.virol.2007.04.010_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.virol.2007.04.010_bib11","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2007.04.010_bib12","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.04.010_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/viro.2001.1345","article-title":"Comparison of vaccine strategies using recombinant env\u2013gag\u2013pol MVA with or without an oligomeric env protein boost in the SHIV rhesus macaque model","volume":"294","author":"Earl","year":"2002","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.virol.2007.04.010_bib14","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein","volume":"77","author":"Earl","year":"2003","journal-title":"J. Virol."},{"issue":"6979","key":"10.1016\/j.virol.2007.04.010_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2007.04.010_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2007.04.010_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/427265","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge","volume":"191","author":"Edghill-Smith","year":"2005","journal-title":"J. Infect Dis."},{"issue":"7","key":"10.1016\/j.virol.2007.04.010_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"issue":"5573","key":"10.1016\/j.virol.2007.04.010_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1126\/science.296.5573.1594","article-title":"Bioterrorism. In search of a kinder, gentler vaccine","volume":"296","author":"Enserink","year":"2002","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.virol.2007.04.010_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6865","key":"10.1016\/j.virol.2007.04.010_bib20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/414748a","article-title":"Transmission potential of smallpox in contemporary populations","volume":"414","author":"Gani","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.virol.2007.04.010_bib21","first-page":"1","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"10.1038\/nm917","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"issue":"5406","key":"10.1016\/j.virol.2007.04.010_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.virol.2007.04.010_bib23","series-title":"Smallpox and Vaccinia","author":"Henderson","year":"1999"},{"issue":"6","key":"10.1016\/j.virol.2007.04.010_bib24","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/jvi.70.6.3741-3752.1996","article-title":"Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara","volume":"70","author":"Hirsch","year":"1996","journal-title":"J. Virol."},{"issue":"Pt. 1","key":"10.1016\/j.virol.2007.04.010_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/0022-1317-83-1-209","article-title":"Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread","volume":"83","author":"Law","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2007.04.010_bib26","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/jvi.66.4.2274-2280.1992","article-title":"Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones","volume":"66","author":"Littaua","year":"1992","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.04.010_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5-6","key":"10.1016\/j.virol.2007.04.010_bib28","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl. Bakteriol. [B]"},{"key":"10.1016\/j.virol.2007.04.010_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-60-2-282","article-title":"Progressive vaccinia with normal antibodies: a case possibly due to deficient cellular immunity","volume":"60","author":"O'Connell","year":"1964","journal-title":"Ann. Intern. Med."},{"issue":"13","key":"10.1016\/j.virol.2007.04.010_bib30","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.04.010_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the western reserve strain and advantages as a vaccine","volume":"74","author":"Ramirez","year":"2000","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2007.04.010_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.virol.2007.04.010_bib33","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1128\/JVI.79.6.3243-3253.2005","article-title":"Signature for long-term vaccine-mediated control of a simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2","volume":"79","author":"Sadagopal","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.04.010_bib34","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox","volume":"52","author":"Sarkar","year":"1975","journal-title":"Bull. World Health Organ"},{"issue":"6","key":"10.1016\/j.virol.2007.04.010_bib35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/0889222041217419","article-title":"Multiprotein HIV type 1 clade B DNA\/MVA vaccine: construction, safety, and immunogenicity in Macaques","volume":"20","author":"Smith","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"12","key":"10.1016\/j.virol.2007.04.010_bib36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1089\/aid.2004.20.1335","article-title":"DNA\/MVA vaccine for HIV Type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime","volume":"20","author":"Smith","year":"2004","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"1-2","key":"10.1016\/j.virol.2007.04.010_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(02)00025-X","article-title":"Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining","volume":"262","author":"Speller","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2007.04.010_bib38","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA vaccination against smallpox: clinical trials of an attenuated live vaccinia virus strain (MVA)","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"12","key":"10.1016\/j.virol.2007.04.010_bib39","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2007.04.010_bib40","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.virol.2007.04.010_bib41","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virol.2007.04.010_bib42","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.virol.2007.04.010_bib43","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"Wyatt","year":"1996","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.virol.2007.04.010_bib44","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.virol.2007.04.010_bib45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/0889222041217428","article-title":"Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component","volume":"20","author":"Wyatt","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:48:43Z","timestamp":1758584923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682207002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0042682207002632"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2007.04.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2007.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}